Related Experiment Video
Updated: Jun 3, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Laparoscopic total mesorectal excision for low rectal cancer
1Division of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, OH, USA. michel.adamina@gmail.com
Surgical Endoscopy
|April 2, 2011
Summary
Laparoscopic total mesorectal excision (LTME) is a safe and effective procedure for low rectal cancer, offering good oncological outcomes. Advanced laparoscopic skills and careful patient selection are crucial for successful LTME.
Area of Science:
- Colorectal Surgery
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Laparoscopic total mesorectal excision (LTME) is an evolving technique for rectal cancer treatment.
- While established as safe and feasible, it remains technically demanding.
- Recent evidence supports its oncological efficacy and improved patient quality of life.
Observation:
- A didactic video demonstrates a five-trocar technique for LTME with coloanal anastomosis in low rectal cancer.
- Key surgical steps, including vascular control, mobilization, and rectal dissection to the pelvic floor, are detailed.
- Principles for achieving a secure anastomosis and avoiding critical structure injury are highlighted.
Findings:
- Ten consecutive patients with low rectal cancer underwent LTME.
- Median operative time was 274 minutes with minimal blood loss (25 ml).
- Tumor height averaged 7 cm from the anal verge; side-to-end or J-pouch coloanal anastomosis was performed, protected by diverting ileostomy, with a median hospital stay of 3 days.
Implications:
- LTME is a safe and effective surgical option for select low rectal cancer patients.
- Mastery of advanced laparoscopic techniques and meticulous patient selection are essential for optimal outcomes.
- This educational video aims to promote wider adoption and enhance the safety of LTME for low rectal cancer.
